Richard Scranton, Chief Scientific Officer at Pacira BioSciences, Inc. (PCRX), sold 13,966 shares at $42.91 ($600K) on 2019-06-04, disclosed to the SEC on 2019-06-06.
Open-market sale of $600k PCRX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.66 | 2,852 | $122K | 20.3% |
| 2 | $42.66 | 2,852 | $122K | 20.3% |
| 3 | $42.91 | 2,074 | $89K | 14.8% |
| 4 | $42.91 | 2,074 | $89K | 14.8% |
| 5 | $43.50 | 4,114 | $179K | 29.8% |
| Total | $42.98 avg | 13,966 |
| $600K |
| 100% |
| Filing → |
| PCRX | SELL | 2018-06-06 | $45K | — | Filing → |